Xinming Life Science and Technology: annual report 2021, 22
Hao Tian Construction Receives Nearly $6 Million from Partial Redemption of Fund Investment
01:29 AM EDT, 07/21/2022 (MT Newswires) -- Hao Tian International Construction (HKG:1341) received $5.8 million from the redemption of 126,068 participating shares in the HT Riverwood Multi-Growth Fun
Xinming Life Technology: annual results announcement for the year ended March 31, 2022
Aceso Life Science, Hao Tian International Unit to Purchase Bonds at $45.2 Million
09:23 PM EDT, 06/22/2022 (MT Newswires) -- True Well, a unit of Aceso Life Science Group (HKG:0474) and Hao Tian International Construction Investment Group (HKG:1341), executed an order with Shanghai
Xinming Life Science and Technology: notice of Board meeting
Aceso Life Science Expects to Deepen Loss in FY22
09:16 PM EDT, 06/12/2022 (MT Newswires) -- Aceso Life Science (HKG:0474) expected to incur a wider loss of HK$572 million ($72.9 million) for the year ended March 31, compared with HK$348 million a ye
Xinming Life Technology: profit warning
Is Aceso Life Science Group Limited (HKG:474) Popular Amongst Insiders?
The big shareholder groups in Aceso Life Science Group Limited (HKG:474) have power over the company. Institutions often own shares in more established companies, while it's not unusual to see insid
Aceso Life Science Sees Fiscal H1 Attributable Loss Drop
10:21 PM EST, 11/28/2021 (MT Newswires) -- Aceso Life Science Group's (HKG:0474) loss attributable to equity holders for the fiscal first half ended Sept. 30 shrunk year over year due to the lower al
The medium-term loss of "Company performance" Xin Ming Life (00474.HK) narrowed to 83 million yuan.
Xinming Life Technology (00474.HK) announced interim results for the six months ended September, with revenue of 166 million yuan, down 14.4% year-on-year. The loss narrowed to 83 million yuan, or 1.18 cents per share, from 434 million yuan in the same period last year. No interim interest.